Pure Global

The Clinical Comparison of Somofilcon A 1 Day and Nelfilcon A Daily Disposable Contact Lenses - Trial NCT04067141

Access comprehensive clinical trial information for NCT04067141 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Completed. The study focuses on Ametropia. Target enrollment is 70 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT04067141
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT04067141
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Clinical Comparison of Somofilcon A 1 Day and Nelfilcon A Daily Disposable Contact Lenses
The Clinical Comparison of the Clariti 1 Day and DAILIES AquaComfort PLUS Daily Disposable Contact Lenses

Study Focus

Ametropia

somofilcon A

Interventional

device

Sponsor & Location

Coopervision, Inc.

Manchester, United Kingdom

Timeline & Enrollment

N/A

Jul 04, 2019

Nov 20, 2019

70 participants

Primary Outcome

Subjective Comfort at Lens Dispensing,Subjective Comfort at Start of Day,Subjective Comfort at End of Day,Overall Subjective Comfort,Overall Subjective Comfort,Subjective Vision,Subjective Vision

Summary

This subject-masked, randomized, bilateral crossover study will compare the clinical
 performance and subjective acceptance of the somofilcon A 1 day soft contact lens with the
 nelfilcon A daily disposable lens when used on a daily wear, daily disposable basis.

ICD-10 Classifications

Amblyopia ex anopsia
Amoebiasis
Amoebiasis, unspecified
Myoclonus
Oesophagitis

Data Source

ClinicalTrials.gov

NCT04067141

Device Trial